Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

hCDC4 variation in osteosarcoma.

Taiqiang Yan¹, Jay S Wunder, Nalan Gokgoz

¹Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5.

Cancer Genetics and Cytogenetics

|August 30, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The contribution of rare germline variants to the immune landscape of breast cancer.

Genome medicine·2026

Same author

Steroids, stress, and body mass index interact to accelerate female pubertal development.

The Journal of clinical endocrinology and metabolism·2026

Same author

Accommodating the Analysis Model in Multiple Imputation for the Weibull Mixture Cure Model: Performance Under Penalized Likelihood.

Statistics in medicine·2026

Same author

Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study.

BMC medicine·2026

Same author

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

NPJ genomic medicine·2025

Same author

Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Cancers·2025

Same journal

Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

Cancer genetics and cytogenetics·2010

Same journal

A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

Cancer genetics and cytogenetics·2010

Same journal

A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

Cancer genetics and cytogenetics·2010

Same journal

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

Cancer genetics and cytogenetics·2010

Same journal

Chromosomal imbalances in urinary bladder paraganglioma.

Cancer genetics and cytogenetics·2010

Same journal

A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

Cancer genetics and cytogenetics·2010

See all related articles

Mutations in the hCDC4 gene are rare in osteosarcoma and do not appear to cause aneuploidy, a condition linked to chromosomal instability in cancers.

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

The hCDC4 gene (Fbw7/Archipelago) encodes an F-box protein critical for targeting cyclin E for degradation.
Disruption of this pathway is linked to chromosomal instability and aneuploidy in various cancers.

Purpose of the Study:

To investigate the role of hCDC4 gene mutations in osteosarcoma aneuploidy.

Main Methods:

Analysis of 147 primary high-grade osteosarcoma specimens and 6 cell lines.
Detection of hCDC4 gene alterations using protein truncation test (PTT) and single-strand conformation polymorphism (SSCP) with sequencing.

Main Results:

PTT showed consistent normal band patterns across all specimens.
SSCP identified two shifts, revealing one in-frame deletion and one silent nucleotide substitution in hCDC4.

Related Experiment Videos

Somatic hCDC4 mutations were found to be infrequent.

Conclusions:

Somatic hCDC4 mutations are uncommon in osteosarcoma.
These mutations are unlikely to be a significant driver of aneuploidy in this tumor type.